—

Hinge Health, Inc. (HNGE) — the peer cohort

As of 2026-10-13 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Hinge Health, Inc. ranks 7 of 9 in its cohort on the Closelooknet composite (56/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
HNGE Hinge Health, Inc. 56 97 63 24 ok 1.7%
HQY HealthEquity Inc 61 58 69 43 info 16.2%
VEEV Veeva Systems Inc Class A 61 97 74 29 neutral 4.7%
BTSG BrightSpring Health Services, Inc. Common Stock 48 64 25 37 ok 15.1%
TEM Tempus AI, Inc. Class A Common Stock 39 72 18 14 bear 34.8%
HALO Halozyme Therapeutics Inc 74 93 94 48 ok 6.2%
DXCM DexCom Inc 66 85 80 35 bull 7.2%
ONC BeiGene, Ltd. 63 75 62 30 info 9.4%
MEDP Medpace Holdings Inc 63 83 74 28 ok 10%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-13

Quick answers

Who are Hinge Health, Inc.'s peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: HealthEquity Inc (HQY), Veeva Systems Inc Class A (VEEV), BrightSpring Health Services, Inc. Common Stock (BTSG), Tempus AI, Inc. Class A Common Stock (TEM), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), BeiGene, Ltd. (ONC), Medpace Holdings Inc (MEDP).

How does HNGE score against its peers?

Hinge Health, Inc.'s composite reads 56/100, ranking 7 of 9 in its cohort as of 2026-10-13; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.